search query: @indexterm Medicine / total: 97
references: 4-13 / 97
« previous page | next page »
 titleyearauthor
4.
The economic dynamics of antibiotic efficacy under open access
Journal of Environmental Economics and Management
2009 : MAY, VOL. 57:3, p. 334-350
 2009 Herrmann, M.
Gaudet, G.
5.
Nanoethics: old wine, new bottles?
Journal of Consumer Policy
2009 : DEC, VOL. 32:4, p. 355-379
 2009 Brownsword, R.
6.
Consumer responses towards non-prescription and prescription drug advertising in the US and Germany
International Journal of Advertising
2008 : VOL. 27:1 p. 99-131
 2008 Diehl, S.
Mueller, B.
Terlutter, R.
7.
Randomized trials of education and medical practices: Strengths and limitations
Economics of innovation and new technology
2007 : JUL-SEP, VOL. 16:5-6, p. 303-306
 2007 Foray, D.
Murnane, R.
Nelson, R. (eds.)
8.
Accounting and medicine: An exploratory investigation into physicians' attitudes toward the use of standard cost-accounting methods in medicine
Journal of Business Ethics
2007 : OCT, VOL. 75:2, p. 137-149
 2007 Thibadoux, G. M.
Scheidt, M.
Luckey, E.
9.
On the will to ignorance in bureaucracy
Economy and Society
2007 : MAY, VOL. 36:2 p. 212-235
 2007 McGoey, L.
10.
Is there a morally right price for anti-retroviral drugs in the developing world?
Business Ethics
2006 : JAN, VOL 15:1, p. 29-43
 2006 Brennan, R.
Baines, P.
11.
Testing drugs on animals: a test case for socially responsible investment
Business Ethics
2005 : APR, VOL 14:2, p. 164-175
 2005 Taylor, R.
12.
International pricing and distribution of therapeutic pharmaceuticals - an ethical minefield
Business Ethics
2005 : APR, VOL 14:2, p. 127-141
 2005 Buckley, J.
Tuama, S. Ó.
13.
A model for addressing stakeholders' concerns about direct-to-consumer advertising of prescription medicines
European Journal of Marketing
2005 : VOL. 39:9-10, p. 1151-1165
 2005 Hoek, J.
Maubach, N.
« previous page | next page »
SCIMA